Lyell Immunopharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Lyell Immunopharma's balance sheet done over the years? Its assets were worth $750,029,000 last year, which is less than in the previous period. 13% of Lyell Immunopharmaโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $95,077,000, which means an decrease by -9% compared compared to last year.

Debt to Assets

Lyell Immunopharma, Inc. (NASDAQ:LYEL): Debt to assets
2019 555631000 147.57M 26.56%
2020 908280000 189.84M 20.9%
2021 1127406000 197.61M 17.53%
2022 937561000 104.30M 11.13%
2023 750029000 95.07M 12.68%

LYEL Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
145.64M123.55M293.82M140.40M96.67M
Short term investments
400.57M516.59M320.96M472.21M339.37M
Net receivables
00000
Inventory
00000
Other current assets
8.46M11.14M11.49M4.92M4.21M
Total current assets
554.68M651.29M626.28M617.54M440.25M
Non-current assets:
Property, Plant and Equipment
142.31M166.26M166.63M124.05M43.70M
Goodwill
00000
Intangible assets
00000
Long term investments
48.50M115.04M330.53M163.44M68.98M
Other non-current assets
4.51M4.96M3.94M3.23M2.68M
Total non-current assets
195.34M286.26M501.12M290.73M115.37M
Total assets
750.02M937.56M1.12B908.28M555.63M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
021.86M4.98M6.09M4.51M
Short term debt
6.27M4.53M1.16M3.61M344K
Total current liabilities
34.51M37.02M46.73M49.28M22.04M
Non-current liabilities:
Long term debt
56.89M63.16M66.65M50.95M27.12M
Deferred tax
00000
Other non-current liabilities
3.66M4.11M4.56M532K98.40M
Total non-current liabilities
60.55M67.28M150.88M140.55M125.53M
Total liabilities
95.07M104.30M197.61M189.84M147.57M
Data sourceData source